US 12,435,087 B2
Modulators of DCN-1 and methods of use thereof
Robert Brian Nicewonger, Tyngsboro, MA (US); Mauricio Cortes, Wellesley, MA (US); Colin Diner, Somerville, MA (US); Sriram Krishnamoorthy, Acton, MA (US); Na Li, Winchester, MA (US); Frank Lovering, Acton, MA (US); Kristen Marino, Stoneham, MA (US); Samuel Miller, Cambridge, MA (US); Qing Tang, Boxborough, MA (US); Atli Thorarensen, Stow, MA (US); Ravi Ujjinamatada, Lexington, MA (US); and David Zhang, West Roxbury, MA (US)
Assigned to Cellarity, Inc., Somerville, MA (US)
Filed by Cellarity, Inc., Somerville, MA (US)
Filed on Nov. 1, 2024, as Appl. No. 18/935,253.
Claims priority of provisional application 63/661,523, filed on Jun. 18, 2024.
Claims priority of provisional application 63/655,542, filed on Jun. 3, 2024.
Claims priority of provisional application 63/547,254, filed on Nov. 3, 2023.
Prior Publication US 2025/0163058 A1, May 22, 2025
Int. Cl. C07D 471/04 (2006.01); C07D 519/00 (2006.01)
CPC C07D 471/04 (2013.01) [C07D 519/00 (2013.01)] 27 Claims
 
1. A compound selected from one of the following:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.